Ligand · IN9
IN9 · 2-[3-(5-mercapto-[1,3,4]thiadiazol-2YL)-ureido]-N-methyl-3-pentafluorophenyl-propionamide
IN9, 2-[3-(5-mercapto-[1,3,4]thiadiazol-2YL)-ureido]-N-methyl-3-pentafluorophenyl-propionamide (C13 H10 F5 N5 O2 S2, 427.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its…
- Component
- IN9
- Formula
- C13 H10 F5 N5 O2 S2
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
IN9 in 2 structures; the first of them:
- 1USN · Crystal structure of the catalytic domain of human fibroblast stromelysin-1 inhibited… · IN9 A300 · binds PHE86, TYR155, ALA165, HIS166, ALA167, TYR168, ALA169, HIS201 and 4 more
- 1USN · Crystal structure of the catalytic domain of human fibroblast stromelysin-1 inhibited… · IN9 A300 · binds PHE86, TYR155, ALA165, HIS166, ALA167, TYR168, ALA169, HIS201 and 4 more
Residues it binds most
HIS 2, ALA 2, PHE 2, TYR 2, GLU 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.